News Trends, News Analysis, News Archive.



Related Articles

companyNews reuters.com

REFILE-UPDATE 2-Elliott takes stake in Akamai Tech, says shares undervalued

Dec 15 (Reuters) - Hedge fund Elliott Management disclosed a 6.5 percent stake in Akamai Technologies on Friday, and said the company's $9.7 billion market value did not reflect the uses of its platform, which speeds up content delivery over the internet.

healthNews reuters.com

Sleep problems tied to female infertility

(Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don’t have trouble sleeping, a recent study suggests.

healthNews reuters.com

Judge blocks Trump administration rules on contraceptive coverage

(Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.

companyNews reuters.com

UPDATE 1-Turkish banker on trial denies helping Iran evade U.S. sanctions

NEW YORK, Dec 15 (Reuters) - An executive at Turkey's majority state-owned Halkbank took the witness stand in a New York courtroom on Friday and denied charges that he participated in a scheme to help Iran evade U.S. sanctions.

domesticNews reuters.com

Former cell phone company executive convicted of text message scam

NEW YORK (Reuters) - A U.S. jury on Friday found the former chief executive of mobile aggregation company Mobile Messenger guilty of defrauding mobile phone customers by charging them millions of dollars for unwanted text messages.

companyNews reuters.com

BRIEF-P&G Says About 972.8 Mln Shares Were Cast In Favor Of Nelson Peltz's Election To Board

* P&G SAYS ABOUT 972.8 MILLION SHARES WERE CAST IN FAVOR OF NELSON PELTZ'S ELECTION TO BOARD, WHILE ABOUT 16.4 MILLION SHARES WERE WITHHELD - SEC FILING Source: (http://bit.ly/2zfyTtB) Further company coverage:

healthNews reuters.com

Executive function declines long-term after 'transient' brain attacks

(Reuters Health) - People who have so-called transient neurological attacks, including brief mini-strokes, may develop cognitive problems that linger for months, a recent study suggests.

domesticNews reuters.com

Turkish banker on trial denies helping Iran evade U.S. sanctions

NEW YORK (Reuters) - An executive at Turkey's majority state-owned Halkbank took the witness stand in a New York courtroom on Friday and denied charges that he participated in a scheme to help Iran evade U.S. sanctions.

healthNews reuters.com

U.S. judge blocks Trump administration birth control rules

(Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.

healthNews reuters.com

Few California pharmacists prescribing birth control

(Reuters Health) - A California law allowing pharmacists to prescribe birth control sought to make it easier for women to obtain contraception, but few drug stores provide the service, a new study finds.

companyNews reuters.com

Pennsylvania man admits to trading on tips about drug company

Dec 15 (Reuters) - A Pennsylvania man pleaded guilty on Friday to charges that he traded on confidential, inside information that a former Celator Pharmaceuticals Inc employee supplied him, including that the company now owned by Jazz Pharmaceuticals Plc was planning to be acquired.

companyNews reuters.com

GLOBAL MARKETS-World shares gain; U.S. yield curve flattest in decade

* Dollar index firmer on tax bill optimism (Updates to Europe close, adds commentary)

healthNews reuters.com

Ebola victims sue Sierra Leone government over mismanaged funds

FREETOWN (Reuters) - Two Ebola survivors in Sierra Leone filed a lawsuit in a regional court on Friday, accusing the government of mismanaging funds during an epidemic that killed more than 3,000 people in the West African nation.

businessNews reuters.com

CSX shares derail after CEO takes unexpected medical leave

(Reuters) - CSX Corp shares skidded as much as 10 percent on Friday, wiping out $4 billion in market value, as the No. 3 U.S. railroad by revenue sought to assure investors its turnaround would progress despite the unexpected medical leave of its chief executive officer.

companyNews reuters.com

BRIEF-Sonic Director Frank Richardson Reports Sale Of 50,000 Shares At $28-$28.39/Share

* SONIC CORP DIRECTOR FRANK RICHARDSON REPORTS OPEN MARKET SALE OF 50,000 SHARES PRICED BETWEEN $28.00 TO $28.39/SHARE- SEC FILING Source text : ( http://bit.ly/2CixX6F ) Further company coverage:

companyNews reuters.com

UPDATE 4-CSX shares derail after CEO takes unexpected medical leave

Dec 15 (Reuters) - CSX Corp shares skidded as much as 10 percent on Friday, wiping out $4 billion in market value, as the No. 3 U.S. railroad by revenue sought to assure investors its turnaround would progress despite the unexpected medical leave of its chief executive officer.

healthNews reuters.com

Phone-based therapy sessions may help dementia caregivers cope

(Reuters Health) - Talk therapy that teaches emotional regulation and coping skills can help people caring for a loved-one with dementia improve their own physical and mental health, German researchers say.

healthNews reuters.com

Tobacco industry trumps as India court cancels stringent health labeling rules

NEW DELHI (Reuters) - An Indian court on Friday quashed federal rules that mandated stringent graphic health warnings on tobacco products, lawyers involved in the case said, in a decision seen as a major victory for the tobacco industry and a setback for health advocates.

companyNews reuters.com

UPDATE 3-CSX shares derail after CEO takes unexpected medical leave

Dec 15 (Reuters) - CSX Corp shares slid as much as 10 percent on Friday, wiping out $4 billion in market value, as the No. 3 U.S. railroad sought to assure investors its turnaround would progress despite the unexpected medical leave of its chief executive officer.

worldNews reuters.com

Turkish minister calls for witness in U.S. trial to be repatriated: ministry sources

ANKARA (Reuters) - Turkey's justice minister has told his U.S. counterpart that a former Turkish police investigator who testified at the trial of a Turkish banker in New York was wanted by Ankara and should be sent back to his country, justice ministry sources said.

companyNews reuters.com

UPDATE 2-CSX shares derail after CEO takes medical leave

Dec 15 (Reuters) - CSX Corp shares slid on Friday as the No. 3 U.S. railroad sought to assure investors its turnaround would progress full steam ahead despite the unexpected medical leave of chief executive officer Hunter Harrison.

worldNews reuters.com

Belgian trial of Paris attacker Abdeslam postponed: court

BRUSSELS (Reuters) - The Belgian trial of one of the suspects behind the 2015 Islamist attacks in Paris has been postponed, a Brussels court said.

companyNews reuters.com

GLOBAL MARKETS-Shares limp toward third week of gains, Bitcoin roars to new high

* Wall Street set to rebound after concerns about U.S. tax reforms

healthNews reuters.com

India state court cancels 2014 federal rule on stringent tobacco pack warnings

NEW DELHI (Reuters) - An Indian court on Friday quashed federal rules that mandated stringent graphic health warnings on tobacco products, lawyers involved in the case said, in a decision seen as a major victory for the tobacco industry and a setback for health advocates.

businessNews reuters.com

CSX shares tumble after CEO's medical leave

(Reuters) - CSX Corp's shares tumbled on Friday in premarket trading after the No. 3 U.S. railroad said Chief Executive Hunter Harrison was taking medical leave for unexpected complications from a recent unspecified illness.

healthNews reuters.com

Finland lets stores sell stronger drinks, health chiefs complain

HELSINKI (Reuters) - Finnish lawmakers narrowly voted on Friday to let grocery stores sell stronger alcoholic drinks, after months of public debate pitting supporters of drinker's rights against health campaigners.

Bribery and Kickbacks nytimes.com

Fancy Sausages and a $2 Million Bribe: A Trial Uncovers Kremlin Infighting

Aleksei V. Ulyukayev, a former economy minister, has been convicted of corruption after a power struggle with the head of the state oil company.

healthNews reuters.com

Novo Nordisk wins EU panel's backing for key diabetes drug

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts' panel issued a positive recommendation on Friday.

healthNews reuters.com

FDA allows Alnylam to restart hemophilia treatment trials

(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday.

companyNews reuters.com

UPDATE 1-FDA allows Alnylam to restart hemophilia treatment trials

Dec 15 (Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday.

companyNews reuters.com

UPDATE 1-Novo Nordisk wins EU panel's backing for key diabetes drug

COPENHAGEN, Dec 15 (Reuters) - Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts' panel issued a positive recommendation on Friday.

healthNews reuters.com

Aclaris's drug to treat common skin growth gets FDA nod

(Reuters) - The U.S. Food and Drug Administration approved Aclaris Therapeutics Inc's topical drug to treat a common kind of skin growth called seborrheic keratoses, the company said on Friday.

companyNews reuters.com

UPDATE 1-Aclaris's drug to treat common skin growth gets FDA nod

Dec 15 (Reuters) - The U.S. Food and Drug Administration approved Aclaris Therapeutics Inc's topical drug to treat a common kind of skin growth called seborrheic keratoses, the company said on Friday.

healthNews reuters.com

Siemens buys Fast Track Diagnostics to boost molecular offering

FRANKFURT (Reuters) - Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is keen to expand as it prepares to float its healthcare unit, Healthineers.

healthNews reuters.com

EU drugs agency says move to new HQ may take longer

LONDON (Reuters) - The European drugs agency said on Friday its new headquarters in Amsterdam may not be ready by the time it has to leave London due to Brexit because the building will not be completed.

healthNews reuters.com

Chinese tourists raid Danish supermarkets for infant milk powder

COPENHAGEN (Reuters) - Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy.

companyNews reuters.com

BRIEF-Univar Announces Pricing Of Sale Of 10 Mln Shares Of Common Stock By Clayton, Dubilier & Rice Llc

* UNIVAR ANNOUNCES PRICING OF SALE OF 10,000,000 SHARES OF COMMON STOCK BY CLAYTON, DUBILIER & RICE LLC

companyNews reuters.com

UPDATE 3-Hong Kong to push ahead with controversial dual-class shares

* HKEX drafting specific rule changes to allow dual-class shares

Weddings and Engagements nytimes.com

Vows: A Digital Message in a Bottle Was Waiting For Him

The couple met briefly on a beach in the Hamptons but didn’t start dating until almost three years later, after he finally found her note on Facebook.

healthNews reuters.com

Thailand battles drug-resistant malaria strains that imperil global campaign

BO RAI, Thailand (Reuters) - Once a smuggling stop for Cambodia's Khmer Rouge guerrillas, Thailand's border town of Bo Rai finds itself on the frontline of a new battle against drug-resistant strains of malaria that could frustrate global attempts to stamp out the disease.

companyNews reuters.com

UPDATE 2-Hong Kong to push ahead with controversial dual-class shares

* HKEX drafting specific rule changes to allow dual-class shares

technologyNews reuters.com

Siemens partners with Amazon as it ramps up industrial software platform

MUNICH (Reuters) - Siemens is partnering with Amazon as it accelerates the rollout of its MindSphere industrial software platform, the core of its bid to dominate the market in digital factory automation.

businessNews reuters.com

Global shares limp toward third week of gains, dollar hobbles

LONDON (Reuters) - World shares fell on Friday and the dollar slipped against major and heavyweight emerging market currencies, as nagging uncertainty about a U.S. tax cuts package dovetailed with broad-based end-of-year caution.

companyNews reuters.com

GLOBAL MARKETS-Shares limp toward third week of gains, dollar hobbles

LONDON, Dec 15 (Reuters) - World shares fell on Friday and the dollar slipped against major and heavyweight emerging market currencies, as nagging uncertainty about a U.S. tax cuts package dovetailed with broad-based end-of-year caution.

companyNews reuters.com

UPDATE 1-Hong Kong to push ahead with controversial dual-class shares

* HKEX drafting specific rule changes to allow dual-class shares

companyNews reuters.com

Hong Kong gearing up to allow controversial dual-class shares

HONG KONG, Dec 15 (Reuters) - Hong Kong is set to allow controversial dual-class shares under rule changes to be proposed by the city's stock exchange as it raises the stakes in its battle against New York for blockbuster Chinese initial public offerings (IPOs).

companyNews reuters.com

BRIEF-Nanya Technology sells 2 mln shares in Micron Technology for $86.9 mln

* Says it sells 2 million shares in Micron Technology Inc for $86.9 million

healthNews reuters.com

Cannabis ingredient holds promise as antipsychotic medicine

LONDON (Reuters) - An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday.

companyNews reuters.com

BRIEF-TSMC Orders Equipment From Applied Materials, Li Jie Industrial, Tun Yi Industrial

Dec 15 (Reuters) - Taiwan Semiconductor Manufacturing Co Ltd :

companyNews reuters.com

GLOBAL MARKETS-Asian shares slip, US tax reform woes dent sentiment

TOKYO, Dec 15 (Reuters) - Asian shares erased earlier modest gains on Friday with sentiment dented by Wall Street's weakness on concerns about the progress of U.S. tax reform, though regional stocks remain on track for a weekly rise.

cnn.com

US scrambles to find unified message on North Korea

A dispute over North Korea has once again laid bare the apparent rift between the White House and the top US diplomat, leading to behind-the-scenes scrambling this week by aides meant to avoid mixed signals about the world's tensest standoff.

businessNews reuters.com

Asian shares slip, U.S. tax reform woes dent sentiment

TOKYO (Reuters) - Asian shares erased earlier modest gains on Friday but were still on track for a weekly rise, as sentiment was hurt by Wall Street's weakness on concerns about the progress of U.S. tax reform.

companyNews reuters.com

GLOBAL MARKETS-Asian shares slip, U.S. tax reform woes dent sentiment

TOKYO, Dec 15 (Reuters) - Asian shares erased earlier modest gains on Friday but were still on track for a weekly rise, as sentiment was hurt by Wall Street's weakness on concerns about the progress of U.S. tax reform.

businessNews reuters.com

Asian shares edge up, on track for weekly gain

TOKYO (Reuters) - Asian shares edged higher on Friday, on track for weekly gains, though sentiment was kept in check by Wall Street's weakness on concerns about the progress of U.S. tax reform.

companyNews reuters.com

GLOBAL MARKETS-Asian shares edge up, on track for weekly gain

TOKYO, Dec 15 (Reuters) - Asian shares edged higher on Friday, on track for weekly gains, though sentiment was kept in check by Wall Street's weakness on concerns about the progress of U.S. tax reform.

companyNews reuters.com

UPDATE 3-Oracle shares tumble as cloud outlook darkens

Dec 14 (Reuters) - Oracle Corp on Thursday forecast current-quarter cloud revenue growth that missed Street expectations after reporting disappointing second-quarter sales in the same business, sending its shares down nearly 7 percent after hours.

companyNews reuters.com

UPDATE 1-Merck's Keytruda fails pivotal gastric cancer trial

Dec 14 (Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of patients with a type of gastric cancer.

healthNews reuters.com

Families of dementia patients see positive effect of social robot seal

(Reuters Health) - Paro, a robotic baby harp seal, seems to improve dementia patients’ mood and increase opportunities for communication with family members, according to a small study.

healthNews reuters.com

Merck's Keytruda fails pivotal gastric cancer trial

(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing Keytruda failed to meet its main goal of extending the lives of patients with a type of gastric cancer.

healthNews reuters.com

Childhood obesity climbing with media use, European doctors warn

(Reuters Health) - Children’s waistlines have been expanding in lock step with the amount of time they spend with televisions, computers, smartphones and tablets, European doctors say.

businessNews reuters.com

Wall St falls as investors fret about tax bill passage

NEW YORK (Reuters) - Major U.S. stock indexes fell on Thursday, with the S&P 500 down the most in a month, as investor worries over potential roadblocks to the Republicans' tax overhaul more than offset optimism over strong retail sales data.

domesticNews reuters.com

Nephews of Venezuela's first lady sentenced to 18 years in U.S. drug case

(Reuters) - Two nephews of Venezuela’s first lady were sentenced to 18 years in prison on Thursday following their convictions in New York on drug trafficking charges.

healthNews reuters.com

Social media may help chronically ill connect to doctors, fellow patients

(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patients’ outlook and reduce their anxiety and depression, a recent U.S. study suggests.

businessNews reuters.com

Wall Street falls as investors fret about tax bill passage

(Reuters) - The S&P 500 and the Dow were lower on Thursday as investors worried about potential roadblocks to Republicans' tax overhaul, offseting their optimism over strong retail sales data.

healthNews reuters.com

U.S. less generous than European nations with development assistance

(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.

healthNews reuters.com

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

healthNews reuters.com

Transgender women may get small breasts with hormones

(Reuters Health) - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests.

companyNews reuters.com

GLOBAL MARKETS-Global shares little changed after central bank meetings

* U.S. stocks down (Updates to Europe close, adds commentary)

healthNews reuters.com

Germany's Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.

domesticNews reuters.com

Turkish banker expected to testify in Iran sanctions trial in New York

(Reuters) - Mehmet Hakan Atilla, a Turkish banker accused of taking part in a scheme to help Iran evade U.S. sanctions, plans to testify in his own defense at his trial in New York, his lawyers said Thursday.

healthNews reuters.com

Brain cells develop more mutations as we age

(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.

companyNews reuters.com

UPDATE 2-European shares lag Wall Street, ECB provides no momentum

* Wind turbine makers boosted by U.S. tax development (Adds closing prices, quotes)

cnn.com

Landmark trial finds possible cure for blood disorder

A gene-therapy trial by London researchers has seen remarkable success in finding a long-term cure for hemophilia A.

topNews reuters.com

World shares little changed amid slate of central bank meetings

NEW YORK (Reuters) - World stock markets were little changed on Thursday after policy meetings from major central banks in Europe, while some U.S. shares were buoyed by news that the Republicans' tax legislation could face final votes in Congress before year-end.

companyNews reuters.com

GLOBAL MARKETS-World shares little changed amid slate of central bank meetings

* Dollar index up (Updates to U.S. trading open; changes byline, dateline, previously LONDON)

companyNews reuters.com

UPDATE 3-Bombardier's 2018 revenue forecast disappoints, shares fall

* Shares down 1.9 pct ahead of investor day at 3:00 p.m. ET (Adds analysts' estimate and comment, background and shares)

companyNews reuters.com

BRIEF-Medicure Acquires License To Sell Cardiovascular Drug In The U.S.

* MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BRANDED CARDIOVASCULAR DRUG IN THE U.S.

companyNews reuters.com

BRIEF-Casa Systems Sees IPO Of 6 Million Shares Of Its Common Stock Priced At $13 Per Share

* CASA SYSTEMS INC SEES IPO OF 6 MILLION SHARES OF ITS COMMON STOCK PRICED AT $13.00 PER SHARE - SEC FILING

companyNews reuters.com

BRIEF-Trovagene Submits Protocol To FDA For Phase 2 Clinical Trial Of Pcm-075 In Combination With Zytiga®

* TROVAGENE SUBMITS PROTOCOL TO FDA FOR PHASE 2 CLINICAL TRIAL OF PCM-075 IN COMBINATION WITH ZYTIGA® FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

companyNews reuters.com

BRIEF-Oncosec Announces Dosing Of First Patient In Registration-Directed Phase 2B Clinical Trial

* ONCOSEC ANNOUNCES DOSING OF FIRST PATIENT IN REGISTRATION-DIRECTED PHASE 2B CLINICAL TRIAL, PISCES/KEYNOTE-695, OF IMMUNOPULSE® IL-12 IN COMBINATION WITH PEMBROLIZUMAB Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

companyNews reuters.com

BRIEF-Amicus Therapeutics Submits New Drug Application To U.S. FDA For Migalastat

* AMICUS THERAPEUTICS SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR MIGALASTAT FOR TREATMENT OF FABRY DISEASE

healthNews reuters.com

With no deal on children's health plan, U.S. states scramble for Plan B

NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.

healthNews reuters.com

Former Philippine President defends controversial dengue program

MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.

healthNews reuters.com

Treating bumps and humps: Dubai opens $10 million camel hospital

DUBAI (Reuters) - Pristine operating theaters and state-of-the-art medical equipment are featured in a new Dubai hospital that opened last week - exclusively for camels.

companyNews reuters.com

UPDATE 1-Banks drag European shares down as investors await Draghi

* Wind turbine makers boosted by U.S. tax development (ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

cnn.com

Overall teen drug use low, but marijuana edging up

Teen drinking, smoking and drug use overall are stable, but the percentage of teens using marijuana is increasing, according to a new report from the University of Michigan's Institute for Social Research.

technologyNews reuters.com

Atos shares fall 2.8 percent after Gemalto rejects takeover bid

PARIS (Reuters) - Shares in Atos fell as much as 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its 4.3 billion euro ($5 billion) takeover bid.

companyNews reuters.com

UPDATE 1-Atos shares fall 2.8 pct after Gemalto rejects takeover bid

PARIS, Dec 14 (Reuters) - Shares in Atos fell as much as 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its 4.3 billion euro ($5 billion) takeover bid.

companyNews reuters.com

Atos shares fall 2.8 pct at open after Gemalto rejects takeover bid

PARIS, Dec 14 (Reuters) - Shares in Atos fell 2.8 percent early on Thursday after Franco-Dutch chip maker Gemalto rejected its takeover bid.

companyNews reuters.com

Banks drag European shares down as investors eye BoE, ECB meetings

LONDON, Dec 14 (Reuters) - Weakness in bank stocks dragged European shares to a downbeat open on Thursday as financial sectors caught the cold from U.S. and Asian trading which suffered from a less hawkish than expected tone from the U.S. Federal Reserve.

companyNews reuters.com

Nikkei slips, telecom shares slump on Rakuten market entry plan

TOKYO, Dec 14 (Reuters) - Japan's Nikkei share average slipped on Thursday, as banks and insurer shares weakened in line with lower interest rates while telecommunications shares withered on news that online retailer Rakuten plans to enter the mobile carrier market.

environmentNews reuters.com

China's industrial heartland struggles in Beijing's fight against smog

SHIJIAZHUANG, China (Reuters) - Severe natural gas shortages are hitting businesses and residents across China's industrial heartland as an unprecedented government effort to clean up an environment devastated by decades of unbridled growth backfires.

companyNews reuters.com

U.S. appeals court vacates conviction of drug distributor over Botox

Dec 13 (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.

companyNews reuters.com

Nikkei edges down, telecom shares slump as Rakuten mulls market entry

TOKYO, Dec 14 (Reuters) - Japan's Nikkei share average erased earlier modest gains on Thursday to edge down, while telecommunications shares withered on news that online retailer Rakuten is weighing entry into the mobile carrier market.

companyNews reuters.com

BRIEF-Proteostasis Therapeutics Prices Public Offering Of 8 Mln Shares At $5/Share

* PROTEOSTASIS THERAPEUTICS PRICES PUBLIC OFFERING OF COMMON STOCK

companyNews reuters.com

Taiwan's Hon Hai Precision plans to list unit's shares in Shanghai

TAIPEI, Dec 14 (Reuters) - Taiwan's Hon Hai Precision Industry Co, the world's largest contract electronics manufacturer, said it planned to list shares of a subsidiary in Shanghai.

companyNews reuters.com

BRIEF-Boulevard Acquisition Says Institutional Investors Agreed To Private Placement Of New Estre Shares For About $130 Mln

* BOULEVARD ACQUISITION CORP. II AND ESTRE AMBIENTAL S.A. TRANSACTION UPDATE

healthNews reuters.com

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.

healthNews reuters.com

Seasonal flu kills more globally than previously thought -U.S. study

CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

companyNews reuters.com

Turkish banker accused of helping Iran launder money seeks mistrial

NEW YORK, Dec 13 (Reuters) - Lawyers for a Turkish banker on trial in New York on charges that he helped Iran evade U.S. sanctions asked a judge on Wednesday to declare a mistrial, saying testimony by a former Turkish police investigator should not have been allowed in court.

businessNews reuters.com

Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.

healthNews reuters.com

Ohio passes law barring abortion over Down syndrome diagnosis

CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

companyNews reuters.com

CORRECTED-BRIEF-Hines Global REIT II Makes Second Public Offering Of Up To $2.50 Bln In Shares Of Its Stock

Dec 12 (Reuters) - Hines Global Reit II: HINES GLOBAL REIT II SAYS MAKING A SECOND PUBLIC OFFERING OF UP TO $2.50 BILLION IN SHARES OF ITS STOCK- SEC FILING

companyNews reuters.com

BRIEF-First Industrial Realty Trust To Issue $300 Mln Notes In Private Offering

* FIRST INDUSTRIAL REALTY TRUST TO ISSUE $300 MILLION OF UNSECURED NOTES IN A PRIVATE PLACEMENT OFFERING Source text for Eikon: Further company coverage:

topNews reuters.com

U.S. judge orders accused New York bomber detained ahead of trial

NEW YORK (Reuters) - The Bangladeshi man accused of attempting a suicide bombing in a busy New York City commuter hub will remain in federal custody while he awaits trial on charges that include supporting a foreign terrorist organization, a judge ruled on Wednesday.

healthNews reuters.com

Head and neck cancer survivors have long-lasting cognitive problems

(Reuters Health) - Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don’t have these tumors, a recent study suggests.

companyNews reuters.com

BRIEF-Jetblue Airways says To Repurchase Up To $750 mln Shares

* AUTHORIZED TO REPURCHASE UP TO $750 MILLION OF SHARES OF STOCK OVER TWO YEARS, BEGINNING JAN 1 Source text : (http://bit.ly/2C2ucSq) Further company coverage:

healthNews reuters.com

Fears of Israeli job cuts at Teva sparks call for general strike

TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.

healthNews reuters.com

Shift work linked to burnout in sleep-deprived nurses

(Reuters Health) - Shift-work nurses who have sleep problems are more likely to experience career burnout that has the potential to compromise their job performance, a small Italian study suggests.

healthNews reuters.com

Music therapy may help ease depression

(Reuters Health) - Traditional depression treatments like psychotherapy or medication might work better for some patients when doctors add a dose of music therapy, a research review suggests.

healthNews reuters.com

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

healthNews reuters.com

Irish parliament committee backs referendum on abortion up to 12 weeks

DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.

healthNews reuters.com

Revance will wait to seek backing for Botox-rival

(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

businessNews reuters.com

Industrial stocks drive Wall Street higher; Fed decision eyed

(Reuters) - A surge in shares of Caterpillar and Boeing lifted the Dow industrials to record level in early afternoon trading on Wednesday, ahead of a widely-expected interest rate hike by the Federal Reserve.

companyNews reuters.com

US STOCKS-Industrial stocks drive Wall St higher; Fed decision eyed

* U.S. consumer prices rise 0.4 pct in Nov, in line with estimates

healthNews reuters.com

Obamacare sign-ups rise but overall enrollment set to fall

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

healthNews reuters.com

Diabetes and obesity both tied to higher risk of cancer

(Reuters Health) - Many cancer cases worldwide may happen at least in part because people are overweight or have diabetes, a new report suggests.

healthNews reuters.com

Obamacare sign-ups rise to 1 million as pace picks up before deadline

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.

healthNews reuters.com

Obamacare sign-ups gain steam as 2018 deadline nears

NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.

healthNews reuters.com

Doner kebabs survive EU lawmaker vote on additives

STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.

healthNews reuters.com

Israel's Teva to cut jobs in restructuring on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.

companyNews reuters.com

UPDATE 2-Lilly's 2018 forecast beats on strength of new drugs

Dec 13 (Reuters) - Eli Lilly and Co on Wednesday forecast 2018 profit and revenue ahead of Wall Street estimates on strong demand for recently launched drugs such as Trulicity and Taltz.

healthNews reuters.com

Half of world's people can't get basic health services: WHO

LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.

healthNews reuters.com

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

companyNews reuters.com

BRIEF-South Atlantic Bancshares To Acquire Atlantic Bancshares

* SOUTH ATLANTIC BANCSHARES, INC. TO ACQUIRE ATLANTIC BANCSHARES, INC.

businessNews reuters.com

Shares eye record high as Fed heads for 2017 hat-trick

LONDON (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike this year and waited to hear from the Federal Reserve on how many more are likely in 2018.

healthNews reuters.com

Philippines' Duterte says dengue campaign carried out in 'good faith'

MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.

businessNews reuters.com

Shares eye record high as Fed heads for hat-trick

LONDON (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike of the year, and waited to hear from the Federal Reserve how many more are likely in 2018.

cnn.com

Tour de France champion failed drug test

Chris Froome, who has been the world's most dominant cyclist in recent years, failed a drugs test in one of cycling's most prestigious races earlier this year.

companyNews reuters.com

GLOBAL MARKETS-Shares eye record high as Fed heads for hat-trick

LONDON, Dec 13 (Reuters) - Global shares were within a whisker of another record high on Wednesday as markets traded on expectations of a third U.S. interest rate hike of the year, and waited to hear from the Federal Reserve how many more are likely in 2018.

United States Politics and Government nytimes.com

Text Messages in Hand, Republicans Plan to Accuse Justice Department of Bias

A chorus of Republicans, including some party mainstays, are questioning the impartiality of the Justice Department and F.B.I. to discredit the Trump investigation.

healthNews reuters.com

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.

companyNews reuters.com

UPDATE 2-France's Sanofi pins hopes on new drugs after setbacks

* CEO says company on track to sell European generics unit (Adds details, shares)

sportsNews reuters.com

Cycling: Froome tested positive for asthma drug during Vuelta

LONDON (Reuters) - Four-time Tour de France winner Chris Froome failed a urine test at the Vuelta a Espana in September but the Briton said on Wednesday he had done nothing wrong.

companyNews reuters.com

UPDATE 1-European shares open on a cautious note ahead of Fed meeting

* Telecom Italia dips, CEO meets gvt (Adds more stocks, context)

companyNews reuters.com

European shares open on a cautious note ahead of Fed meeting

LONDON, Dec 13 (Reuters) - European bourses opened on a cautious note on Wednesday despite gains on Wall Street and in Asia as investors await a U.S. Federal reserve meeting and assess the political implications of Donald Trump's setback in a bitter Senate election in Alabama.

healthNews reuters.com

Sanofi sees nine regulatory submissions over next 18 months

PARIS (Reuters) - Sanofi said on Wednesday it expected to file nine regulatory submissions for new drugs over the next 18 months and that its pipeline of new products would support long-term growth.

healthNews reuters.com

Teva Pharm to unveil restructuring plan on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include layoffs, the Calcalist financial news website said on Wednesday.

businessNews reuters.com

Asian shares up, dollar dips as Republicans lose Alabama Senate race

TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.

companyNews reuters.com

GLOBAL MARKETS-Asian shares up, dollar dips as Republicans lose Alabama Senate race

TOKYO, Dec 13 (Reuters) - U.S. stock futures, Treasury yields and the dollar dipped on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares gained as crude oil futures took back some lost ground.

companyNews reuters.com

Nikkei dented by weaker tech shares; Shikoku Electric stumbles

TOKYO, Dec 13 (Reuters) - Japan's Nikkei share average ended lower on Wednesday after tech stocks lost ground as they tracked their weaker U.S. counterparts, while Shikoku Electric slumped after a court ruled against the restart of one of its nuclear reactors.

cnn.com

Opinion: Alabama's message to women: You matter

Three words resounded out of the election of Doug Jones to the US Senate: women's stories matter.

businessNews reuters.com

Asian shares up, dollar dips as Democrat wins Alabama Senate race

TOKYO (Reuters) - U.S. stock futures, Treasury yields and the dollar fell on Wednesday as Democrat Doug Jones beat Republican Roy Moore in a bitter U.S. Senate race in Alabama, while Asian shares edged up as crude oil futures took back lost ground.

companyNews reuters.com

GLOBAL MARKETS-Asian shares up, dollar dips as Democrat wins Alabama Senate race

* Democrat seen beating Trump-backed candidate in Senate race

companyNews reuters.com

BRIEF-Blueprint Medicines Prices Public Offering Of 3.70 Mln Shares At $81.00/Share

* BLUEPRINT MEDICINES ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK

cnn.com

FBI agent's anti-Trump messages released to Congress

A series of text messages exchanged between top FBI employees that were critical of then-presidential candidate Donald Trump were released to lawmakers Tuesday evening on Capitol Hill amid increasing demands to see them, according to documents reviewed by CNN.

healthNews reuters.com

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.

companyNews reuters.com

Nikkei edges lower as weaker tech shares offset boost from financials

TOKYO, Dec 13 (Reuters) - Japan's Nikkei share average edged lower on Wednesday morning after tech stocks lost ground as they tracked their weaker U.S. counterparts, offsetting gains in the financial space.

companyNews reuters.com

BRIEF-Bluebird Bio Prices Public Offering Of 3.2 Mln Shares At $185/Share

* BLUEBIRD BIO ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

businessNews reuters.com

Asian shares flat, Fed hike expectations underpin dollar

TOKYO (Reuters) - Asian shares were treading water in early trade on Wednesday as crude oil futures steadied after a selloff, while a widely expected interest rate hike from the Federal Reserve underpinned the dollar.

companyNews reuters.com

GLOBAL MARKETS-Asian shares flat, Fed hike expectations underpin dollar

TOKYO, Dec 13 (Reuters) - Asian shares were treading water in early trade on Wednesday as crude oil futures steadied after a selloff, while a widely expected interest rate hike from the Federal Reserve underpinned the dollar.

companyNews reuters.com

BRIEF-Iron Mountain Says Public Offering Of 14.5 Mln Common Shares Priced At $37 Per Share

* SAYS PUBLIC OFFERING OF 14.5 MILLION COMMON SHARES PRICED AT $37.00PER SHARE Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-‍Alimentation Couche-Tard Founder Alain Bouchard To Sell Shares

* ALIMENTATION COUCHE-TARD- ALAIN BOUCHARD HAS INFORMED CORPORATION OF HIS INTENTION TO SELL 200,000 CLASS B SUBORDINATED VOTING SHARES THAT HE HOLDS​

healthNews reuters.com

U.S. judge questions Trump administration on birth control rules

OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.

companyNews reuters.com

BRIEF-Heartland Financial USA Announces Plan To Acquire First Bank Lubbock Bancshares In Texas

* HEARTLAND FINANCIAL USA, INC. ANNOUNCES PLAN TO ACQUIRE FIRST BANK LUBBOCK BANCSHARES, INC. IN TEXAS

healthNews reuters.com

Republicans propose to delay, pause Obamacare taxes

WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.

companyNews reuters.com

BRIEF-Hines Global Makes Second Public Offering Of Up To $2.50 Bln In Shares Of Its Stock

* HINES GLOBAL REIT SAYS MAKING A SECOND PUBLIC OFFERING OF UP TO $2.50 BILLION IN SHARES OF ITS STOCK- SEC FILING Source text: [http://bit.ly/2AeIqiE] Further company coverage:

healthNews reuters.com

Many young U.S. men at high risk for HIV do not take anti-HIV pill

(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

healthNews reuters.com

Older women should not take hormones to prevent chronic diseases

(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.

companyNews reuters.com

UPDATE 2-Shares in Brazilian homebuilder MRV shoot up with ambitious growth plan

SAO PAULO, Dec 12 (Reuters) - Shares in Brazilian homebuilder MRV Engenharia e Participações SA shot up more than 5 percent on Tuesday as executives unveiled plans to start construction on 50,000 new home units in 2018, which could generate more than 7 billion reais ($2.1 billion) in sales.

healthNews reuters.com

Hearing loss may be a risk factor for dementia

(Reuters Health) - Older adults who develop hearing loss may more likely to experience dementia and cognitive decline than their counterparts without hearing problems, a research review suggests.

healthNews reuters.com

Motorcycle passengers have higher head injury risks

Reuters Health - Motorcycle passengers are less likely than drivers to wear helmets, and they are more likely to suffer traumatic brain injuries in crashes, a U.S. study suggests.

cnn.com

Anchor shares post-brain surgery video

Six months after undergoing brain surgery, former co-anchor of "E! News" Maria Menounos shares a video taken 24 hours after the life-saving procedure.

healthNews reuters.com

'Heat-not-burn' tobacco may be safer but still a risk: UK panel

LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.

healthNews reuters.com

EU health and food safety experts warn of stubborn salmonella

LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.

businessNews reuters.com

Sanofi investors hungry for drug progress and deal news

PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.

companyNews reuters.com

BRIEF-Tapimmune Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Treating Triple-Negative Breast Cancer

* TAPIMMUNE ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 2 CLINICAL TRIAL FOR TREATING TRIPLE-NEGATIVE BREAST CANCER FUNDED BY U.S. DEPARTMENT OF DEFENSE

healthNews reuters.com

Cholera resurges in Zambian capital Lusaka, WHO says

GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.

Brazil nytimes.com

Brazil Fights H.I.V. Spike in Youths With Free Preventive Drug

The country is the first in Latin America to make a blue pill called PrEP an integral part of its health care policy.

companyNews reuters.com

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 (Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

companyNews reuters.com

BRIEF-‍Altice Nv Altice Intends To Reduce Its Share Capital By Cancelling Treasury Shares​

* On June 28, 2017, the general meeting of Altice N.V. granted authority to the Board to cancel common shares A and common shares B in the share capital of the company held by the company.

businessNews reuters.com

Asia shares take a time out, Brent breaks above $65

SYDNEY (Reuters) - Asian shares took a small step back on Tuesday after three straight sessions of gains, with markets consolidating in the hope an upswing in global growth could outlast a likely hike in U.S. borrowing costs this week.

companyNews reuters.com

GLOBAL MARKETS-Asia shares take a time out, Brent breaks above $65

* Brent crude tops $65 a barrel for first time since mid-2015

businessNews reuters.com

Asia shares take breather, Brent breaks above $65

SYDNEY (Reuters) - Asian shares took a breather on Tuesday after three straight sessions of gains, with markets consolidating in the hope an upswing in global growth could outlast a likely hike in U.S. borrowing costs this week.

companyNews reuters.com

GLOBAL MARKETS-Asia shares take breather, Brent breaks above $65

* Brent crude tops $65 a barrel for first time since mid-2015

healthNews reuters.com

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

politicsNews reuters.com

Republican Moore embraces Trump message on eve of Alabama election

BIRMINGHAM, Ala. (Reuters) - Republican U.S. Senate candidate Roy Moore touted his ties to President Donald Trump on Monday in the final stretch of an election campaign in Alabama in which Moore has battled accusations of sexual misconduct toward teenagers.

companyNews reuters.com

BRIEF-Trico Bancshares Enters San Francisco Bay Area With Acquisition Of FNB Bancorp

* ENTERS SAN FRANCISCO BAY AREA WITH ACQUISITION OF FNB BANCORP

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

domesticNews reuters.com

U.S. judge warns of mistrial in Nevada rancher Bundy's trial

LAS VEGAS (Reuters) - A U.S. federal judge in the criminal conspiracy trial of Nevada rancher Cliven Bundy and three other men on Monday warned that prosecutors' failure to produce documents that could support defense arguments could lead to a mistrial.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

companyNews reuters.com

BRIEF-Bookrunner Says Detsky Mir Final Deal Size Expected To Be 46.5mm Shares in accelerated bookbuilt offering

* BLOCK TRADE - DETSKY MIR: BOOKRUNNER SAYS TRANSACTION EXPECTED TO PRICE AT RUB 90 PER SHARE; FINAL DEAL SIZE EXPECTED TO BE 46.5MM SHARES AT THIS PRICE‍​ Further company coverage:

companyNews reuters.com

BRIEF-Agios Pharmaceuticals Presents New Safety Data From Study on Leukemia Drug

* PRESENTS NEW SAFETY DATA FROM PHASE 1 EXPANSION STUDY EVALUATING ORAL IVOSIDENIB IN PATIENTS WITH R/R AML AND IDH1 MUTATION

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

Diamonds nytimes.com

Basics: Precious Gems Bear Messages From Earth’s Molten Heart

We may covet gemstones for their beauty, but their real value lies in what they tell scientists about the extreme forces at work deep underground.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

cnn.com

Secret message apps on the rise at work

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

businessNews reuters.com

Ryanair pilots in Dublin vote in favor of industrial action

DUBLIN (Reuters) - Pilots employed directly by Ryanair in Dublin, its second largest base, have voted overwhelmingly in favor of taking industrial action in a growing dispute over the airline's collective bargaining system, the IMPACT trade union said on Monday.

cnn.com

Drug trial shows promising results to fight Huntington's disease

For the first time, an experimental drug has reduced levels of the toxic protein that causes Huntington's disease in humans.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

UPDATE 1-'Ground-breaking' new drug gives hope in Huntington's disease

LONDON, Dec 11 (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Suning Commerce sells 5.5 mln shares in Alibaba, expects net income of 3.25 bln yuan

* SAYS IT EXPECTS NET INCOME OF 3.25 BILLION YUAN ($491.16 million) AFTER SELLING 5.5 MILLION SHARES IN ALIBABA GROUP HOLDING Source text in Chinese: http://bit.ly/2B32uI0 Further company coverage: ($1 = 6.6170 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

cnn.com

Teen has a blunt message for Aetna